| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |